Financial

The current funding environment is notoriously challenging, particularly in the Ortho space. On a discussion with the BoneChat community, finance […]

The Big Orthos continue to grow with their access advantages, new products from M&A, and organized sales force. The pattern

I received a call from an orthopedic surgeon: “How do I break into venture capital as a physician?” The answer

Venture money has been tight for over three years and counting, so a few ortho businesses are tapping into the

Tiger’s 5 quick takes: 1/ Ortho Access Wars This move validates my point that innovating in Ortho has gotten harder

Why Read? As a leader of a nimble ortho company navigating tight margins and fierce competition, this article arms you

I recently covered Carlsmed’s bold $100M IPO bid, noting how rare orthopedic offerings have been in recent years. Now, Shoulder

Disclaimer: This is not legal advice or financial advice and I do not own any Treace stock. OK, not let’s

This acquisition story is complicated and changing day-to-day. Let me try to make sense of this saga. Websites – https://integrum.se/

Why Read? Read this if you want to understand hospital value analysis demystifies procurement barriers for small orthopedics device companies.

In an era where venture capital flows like molasses—particularly for fledgling spine startups navigating regulatory hurdles, market saturation, and investor

This article is worth reading because it uncovers the harsh realities and cautionary tales behind failed orthopedic startups, offering invaluable

This concerning trend is gaining momentum: major hospital networks are increasingly resistant to adopting innovative orthopedic devices. Metaphorically speaking, these

This is a sign of the times. In the spine sector, a stark imbalance persists: the pool of spine surgeons

This article dissects Montagu Private Equity’s ambitious rollup of three orthopedic device companies, comparing it to their proven Nemera playbook,

Quick Summary restor3d’s $104 million investment from Partners Group, including $65 million in new equity, offers significant advantages: it accelerates

By exploring the intellectual property feud between Globus Medical and Life Spine, you will uncover the intricacies of a high-stakes

For orthopedic companies seeking funding to innovate, grow, or scale, understanding the landscape of potential investors is crucial. Based on

I’m scratching my head here. ZB, the world’s leader in total joint implant sales, just dropped $177M (before earnouts) to

Disclaimer: This is not financial advice, and investors should conduct their own due diligence before making any investment decisions. Tiger’s

Let’s talk about Press Releases. I have found an inverse correlation between success and press releases (illustrated below). When I

Moving into the second half of 2025, I am anticipating the reopening of the IPO market which is expected to

A compelling trend emerged in our ortho industry: companies are staying private far longer than they used to. IPOs have

Discover why VC scouts are vital for orthopedic medtech startups. Learn how scouts with insights like Tiger unlock funding and

I just read an article after Medtronic’s earnings call – Why Medtronic plans to spin out its diabetes business. Quick

“The Big Orthos are hunting for early stage orthos with cameras, not guns.” I have conversations with startup leaders each week

Wow, Anika’s stock tanked post-Q1 2025 earnings due to a 10% revenue drop, lower OEM pricing, manufacturing issues, and reduced

The orthopedic industry is a dynamic landscape where innovation, strategy, and execution determine which companies thrive and which languish. While

Key Points Research suggests Trump’s tariffs are likely impacting US-based orthopedic medical device companies, increasing costs and disrupting supply chains.

The ONLY orthopedic-related company to pursue the public markets since Monogram (2023) and Treace (2021) is HingeHealth – https://www.hingehealth.com/ On March

The acquisition of Amplitude Surgical by Zydus Lifesciences is highly significant for the hip and knee orthopedic industry for several

I have been writing about how simplicity is the answer, choice is a tax on everyone, and some orthopedic device

We are the guilty ones. The orthopedic device industry has collectively conditioned our customers to expect unrestricted access to any

Website – https://nanovistechnology.com/ Medtronic buys Nanovis’ nano technology for use in spine implants (MedTechDive) Medtronic will use the technology to

Recent developments at Mass General Brigham (MGB), where the health system announced the largest layoffs in its history, suggest a

Times are getting strange. I have seen a disturbing trend where some capital allocators engage in predatory practices, particularly targeting

This one was hard to gather my thoughts on. It’s kinda boring when a public company buys another public company

VB website – https://www.vbllc.com I am going to share thoughts on this interesting acquisition. I don’t have any inside information

Websites – https://www.orthosol.com/ and https://meshworksimplants.com/ The strategic importance of OrthoSolutions acquiring Meshworks lies in enhancing patient care through personalized 3D-printed

My 7 thoughts. The merger of Tyber Medical, Intech, and Resolve Surgical Technologies, facilitated by Montagu, is driven by several

Medline announces confidential submission of draft registration statement for proposed initial public offering (press release) Medline UNITE, which is part